[1] Marín-Peñalver JJ,Martín-Timón I,Sevillano-Collantes C,et al.Update on the treatment of type 2 diabetes mellitus[J].World J Diabetes,2016,7(17):354-395.
[2] Tesfaye S,Selvarajah D.Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy[J].Diabetes Metab Res Rev,2012,28(Suppl 1):8-14.
[3] 董琪,李全民.糖尿病周围神经病变发病机制的研究进展[J].现代仪器与医疗,2015,21(2):20-22,34.
[4] 王绍欣,谢云.AGE-RAGE系统与糖尿病周围神经病变[J].中国糖尿病杂志,2008,16(6):379-381.
[5] Wada R,Yagihashi S.Role of advanced glyeation end products and their receptors in development of diabetic neuropath[J].Ann N Y Acad Sci,2005,1043:598-604.
[6] Yamagishi S,Nakamura N,Suematsu M,et al.Advanced Glycation End Products:A Molecular Target for Vascular Complications in Diabetes[J].Mol Med,2015,21( Suppl 1):s32-40.
[7] Fukami K,Yamagishi S,Okuda S.Role of AGEs-RAGE system in cardiovascular disease[J].Curr Pharm Des,2014,20(14):2395-2402.
[8] 彭丽媛,王海澜.糖尿病微血管障碍的发生机制及其与周围神经病变的关系[J].医学综述,2013,19(3):513-515.
[9] 陈红霞,张喆.糖尿病周围神经病变的病理生理机制研究进展[J].国际内分泌代谢杂志,2007,27(z1):47-49.
[10] 余俊先,张银娣.糖尿病周围神经病变的发病机制及药物治疗[J].中国医刊,2007,42(9):66-69.
[11] Wiggin TD,Sullivan KA,Pop-Busui R,et al.Elevated triglycerides correlate with progression of diabetic neuropathy[J].Diabetes,2009,58(7):1634-1640.
[12] Vincent AM,McLean LL,Backus C,et al.Short-term hyperglycemia produces oxidative damage and apoptosis in neurons[J].FASEB J, 2005,19(6):638-640.
[13] Edwards JL,Vincent AM,Cheng HT,et al.Diabetic neuropathy: mechanisms to management[J]. Pharmacol Ther,2008,120(1):1-34.
[14] Pan HZ,Zhang L,Guo MY,et al.The oxidative stress status in diabetes mellitus and diabetic nephropathy[J].Acta Diabetol, 2010,47(Suppl 1):71-76.
[15] Vinik AI.Diabetic neuropathy:pathogenesis and therapy[J].Am J Med,1999,107(2B):17-26.
[16] Lopez PH,Zhang G,Zhang J,et al.Passive transfer of IgG anti-GM1 antibodies impairs peripheral nerve repair[J].J Neurosci,2010,30(28):9533-9541.
[17] Kim BJ,Jin HK,Bae JS.Bone marrow-derived mesenchymal stem cells improve the functioning of neurotrophic factors in a mouse model of diabetic neuropathy[J].Lab Anim Res,2011,27(2): 171-176.
[18] Perkins B,Bril V.Electrophysiologic testing in diabetic neuropathy[J].Handb Clin Neurol, 2014,126(126):235-248.
[19] Ziegber D,Papanas N,Zhivov A,et al.Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes[J].Diabetes,2014,63(7): 2454-2463.
[20] Richards TA,Curtin CM.Posterior interosseous nerve: an alternative to sural nerve biopsy[J]. Plast Reconstr Surg,2010,126(4):213-214.
[21] 梁思虹,陈小燕.糖尿病周围神经病变血清标志物的研究进展[J].医学综述,2017,23(4):733-737.
[22] 郑娟,沈大跃,潘珺,等.硫辛酸联合甲钴胺治疗糖尿病周围神经病变50例[J].中国药业,2013,22(13):68-69.
[23] 韦海涛,陈冰.依帕司他联合甲钴胺治疗糖尿病周围神经病变临床疗效观察[J].现代诊断与治疗,2015,26(20):4650-4651.
[24] 肖华. 糖尿病周围神经病变的药物治疗进展[J].海峡药学,2015,27(8):108-109.
[25] 刘国,佟秋佳.糖尿病周围神经病变中医治疗进展[J].中国临床医生杂志,2016,44(3):30-32.
[26] 刘洁. 中医外治法治疗糖尿病周围神经病变概况[J].云南中医中药杂志,2015,36(1):86-88.
[27] 陈茹. 周围神经减压术治疗糖尿病引起的肢体麻木研究[J].现代养生(下半月版),2017,(1):31. |
